Overcoming β-Cell Dysfunction in Type 2 Diabetes Mellitus: CD36 Inhibition and Antioxidant System
Type 2 diabetes mellitus (T2DM) is marked by chronic hyperglycemia, gradually worsening β-cell failure, and insulin resistance. Glucotoxicity and oxidative stress cause β-cell failure by increasing reactive oxygen species (ROS) production, impairing insulin secretion, and disrupting transcription fa...
Saved in:
Main Authors: | Il Rae Park, Yong Geun Chung, Kyu Chang Won |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Diabetes Association
2025-01-01
|
Series: | Diabetes & Metabolism Journal |
Subjects: | |
Online Access: | http://e-dmj.org/upload/pdf/dmj-2024-0796.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Deciphering the Role of CD36 in Gestational Diabetes Mellitus: Linking Fatty Acid Metabolism and Inflammation in Disease Pathogenesis
by: Huang L, et al.
Published: (2025-02-01) -
A CD36-based prediction model for sepsis-induced myocardial injury
by: Yun Xie, et al.
Published: (2025-04-01) -
TMEM135 deficiency improves hepatic steatosis by suppressing CD36 in a SIRT1-dependent manner
by: Arun Chhetri, et al.
Published: (2025-02-01) -
Niraparib restricts intraperitoneal metastases of ovarian cancer by eliciting CD36-dependent ferroptosis
by: Ning Jin, et al.
Published: (2025-03-01) -
Discovery and in vitro characterization of a human anti-CD36 scFv
by: Cecilia Mata-Cruz, et al.
Published: (2025-02-01)